The inhibition of myeloperoxidase and collagenase enzymes, which have a role in skin regeneration, wound healing, cardiovascular diseases, inflammatory diseases, neurodegenerative diseases, kidney diseases and immune-mediated diseases, is very important for developing and discovering new drugs [55,56]. Here, MPO is linked to cardiovascular disorder.